Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRD5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
REEP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SPHAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBXO9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIBCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACADSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928589 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNLL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OIP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on